Injection site reaction

Drugs with this side effect

• 17-hydroxyprogesterone: postmarketing
• 2-hydroxysuccinaldehyde: postmarketing
• 5-azacytidine: very common, 0% - 29.1%
• AMD3100: 0% - 34%
• Anidulafungin
• BCNU
• Bivalirudin: postmarketing
• EACA
• Enfuvirtide
• Eptifibatide
• FK463
• Fe(III: 33%
• Forteo: postmarketing
• Gd-DTPA
• Gd-EOB-DTPA
• Glat copolymer
• Goserelin
• Hoe 140
• Humalog
• ICI 182,780: postmarketing
• Implanon
• Insulin: common
• K779: 23% - 35%
• LY146032: 5.8% - 7.7%
• Lantus
• Leuprorelin: postmarketing, 9%
• Lyxumia
• Meropenem anhydrous
• Metrodin: postmarketing, very common, 4% - 6.67%
• NovoLog
• Octreotide
• Optison
• Org 37462
• PGE1
• Refludan
• SOM230: 17.1% - 17.5%
• SU5416
• Signifor: 17.1% - 17.5%
• SonoVue
• Supremon: 5.4% - 11.9%
• Symlin: postmarketing
• Triptorelin: 3%
• acetaminophen: 2.67% - 14.7%
• adenosine: postmarketing
• allopurinol
• amiodarone: postmarketing
• amobarbital
• amphotericin B
• amsacrine
• apomorphine
• arginine
• aripiprazole
• atosiban
• atropine
• benzathine penicillin
• bicalutamide
• boceprevir
• bortezomib
• buprenorphine
• capecitabine
• carboplatin
• carnitine: 27% - 38%
• celecoxib
• cetrorelix
• choline
• cidofovir
• ciprofloxacin
• cladribine: very common, 9% - 19%
• copolymer 1: 6.5%
• cyclizine
• cyproterone
• cyproterone acetate
• cytarabine
• cytokinin
• dalteparin
• dantrolene: postmarketing
• deferoxamine: uncommon, very common
• degarelix
• demethyl
• dexrazoxane
• dextrorphan
• diazepam
• diclofenac: common
• dicyclomine: postmarketing
• diethylenetriaminepentaacetic acid
• diltiazem
• dipyridamole
• docetaxel: 6%
• doxorubicin: 2-20%
• ecallantide: 3% - 7%
• exenatide: postmarketing, common
• fenoldopam
• ferumoxytol: postmarketing
• florbetaben
• florbetapir: uncommon, 0.5%
• flumazenil
• fosphenytoin: frequent
• gadobenate dimeglumine: postmarketing
• gadodiamide
• gadolinium: postmarketing, 0.3% - 1.53%
• gadopentetate: postmarketing
• gadoteridol
• gadoversetamide: 0.962% - 3.04%
• ganciclovir
• gatifloxacin
• gemcitabine: postmarketing, 4%
• glutamine: 0% - 25%
• glycopyrrolate
• gonadorelin: common, 3.39% - 4.65%
• haloperidol
• hepatitis B vaccines: common
• histamine
• hydromorphone: postmarketing
• hydroxocobalamin
• ibandronate
• ibuprofen
• insulin detemir: 0.6% - 1.7%
• iodixanol
• iohexol
• iopromide
• iron sucrose
• ketorolac tromethamine: postmarketing
• lanreotide: postmarketing
• lansoprazole: 1%
• leuprorelin acetate: 8.16% - 37.5%
• liraglutide: postmarketing
• lorazepam: infrequent, 0.769%
• mTHPC: common
• medroxyprogesterone: 5%
• medroxyprogesterone acetate: 5%
• melphalan: 50%
• meropenem
• mesna: postmarketing, 6.7% - 10%
• methylene blue
• methylnaltrexone: common
• methylprednisolone sodium succinate
• mipomersen: 5% - 84%
• mitomycin C
• mivacurium
• moxifloxacin: 1%
• mycophenolate mofetil
• nalbuphine
• naloxone
• naltrexone: 3%
• nicardipine: 1.4%
• ofloxacin
• olanzapine
• omeprazole: 1.7% - 4.27%
• ondansetron: common, 3.84%
• oxaliplatin: very common, 0% - 11.1%
• oxymorphone
• paclitaxel: postmarketing, rare, common, very common, 1% - 13%
• paliperidone
• palonosetron: postmarketing
• pantoprazole
• parecoxib
• pegaptanib
• penicillin
• pentobarbital
• phenobarbital
• phentolamine
• phenytoin: frequent
• piperacillin: uncommon
• pregabalin: rare
• promethazine
• prostacyclin
• rabeprazole
• radium
• rasburicase
• retinoic acid: 17%
• ribavirin: very common, 5% - 59%
• riluzole: infrequent
• risperidone: postmarketing, infrequent
• ropivacaine: 0.2% - 2.1%
• salmon calcitonin acetate: rare, uncommon
• secobarbital
• sodium ferric gluconate: 33%
• sumatriptan: 59%
• technetium-99m
• teduglutide: 21%
• tesamorelin: 1.3% - 4.6%
• testosterone: postmarketing
• testosterone undecanoate
• tigecycline: postmarketing, uncommon, common
• trabectedin
• triamcinolone acetonide
• ustekinumab: uncommon
• valproate
• vecuronium
• verteporfin
• vinflunine
• vinorelbine: 0% - 38%
• vitamin K
• voriconazole: common
• x M22
• zoledronic acid: uncommon
• zuclopenthixol